Guangyu Bio is an in vivo flow cytometry technology R&D and application service provider. Recently, Guangyu Bio completed an angel round of financing of tens of millions of RMB. It was exclusively invested by Weidu Venture Capital, a professional medical investment institution. The funds are mainly used for R&D investment and clinical Technological innovation.
This article is reproduced from: https://www.itjuzi.com/investevent/13488775
This site is for inclusion only, and the copyright belongs to the original author.